Mizuho Securities Downgrades BioXcel Therapeutics (BTAI) to Neutral, 'Reset Expectations'
Tweet Send to a Friend
(Updated - August 15, 2023 6:49 AM EDT)
Mizuho Securities analyst Graig Suvannavejh downgraded BioXcel Therapeutics (NASDAQ: BTAI) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Mizuho Securities analyst Graig Suvannavejh downgraded BioXcel Therapeutics (NASDAQ: BTAI) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
